Progesterone and diabetic wound repair: an evidence-gap review of indirect preclinical findings
Abstract
The case for natural progesterone in diabetic wound repair rests on indirect preclinical findings, not demonstrated wound-healing efficacy. This evidence-gap review separates natural progesterone, its neuroactive metabolites and synthetic progestins, and distinguishes ligand interventions from studies of similarly named targets. Structured searches on 29 August 2026 and a targeted check on 30 September 2026 identified no natural-progesterone intervention measuring healing efficacy in a diabetic cutaneous wound. Diabetic-neuropathy experiments report selected neural improvements, but nerve conduction or intraepidermal fibre density does not establish functional re-epithelialisation, glycaemia-independent benefit or recovery of protective sensation at a wound. Findings in non-diabetic skin and other tissues are heterogeneous. Murine dorsal wounds also differ from human diabetic foot ulcers in contraction, loading, chronicity and vascular disease. A proposed neural mechanism must therefore be tested against epithelial and barrier outcomes, adequate perfusion and matched glycaemic exposure. Opposing metabolic and endothelial findings, together with compound- and route-specific safety concerns, preclude a general prediction of benefit. The review provides an auditable evidence map and falsifiable experimental priorities; it does not support clinical progesterone supplementation for diabetes-related foot ulcers.
Related
- Exercise-Based Management of Diabetic Cardiomyopathy: Preclinical Mechanisms, Clinical Evidence, and Translational Strategies.
- Traditional Chinese Medicine for Diabetic Kidney Disease: Predominantly Preclinical Evidence, Mechanistic Pathways, and Translational Challenges.
- Screening strategy versus drug efficacy: Revisiting the evidence for vaginal progesterone in short cervix
- Allogeneic Human Bone Marrow‐Derived Mesenchymal Stem Cells Accelerate Diabetic Wound Healing via Inflammation Suppression and Angiogenesis Promotion: A Preclinical Study
- Current Role of Endoscopic Ultrasonography in the Early Detection of Pancreatic Cancer: Recognition of Indirect Imaging Findings and Diagnostic Strategy
BibTeX
@article{chen2026progesterone,
title = {{Progesterone and diabetic wound repair: an evidence-gap review of indirect preclinical findings}},
author = {Jianmin Chen and Pu Gao and Xiao Zhang and Cheng Long},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.2016207},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.2016207},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Progesterone and diabetic wound repair: an evidence-gap review of indirect preclinical findings
AU - Jianmin Chen
AU - Pu Gao
AU - Xiao Zhang
AU - Cheng Long
PY - 2026
DA - 2026/11/05
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.2016207
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.2016207
AB - The case for natural progesterone in diabetic wound repair rests on indirect preclinical findings, not demonstrated wound-healing efficacy. This evidence-gap review separates natural progesterone, its neuroactive metabolites and synthetic progestins, and distinguishes ligand interventions from studies of similarly named targets. Structured searches on 29 August 2026 and a targeted check on 30 September 2026 identified no natural-progesterone intervention measuring healing efficacy in a diabetic cutaneous wound. Diabetic-neuropathy experiments report selected neural improvements, but nerve conduction or intraepidermal fibre density does not establish functional re-epithelialisation, glycaemia-independent benefit or recovery of protective sensation at a wound. Findings in non-diabetic skin and other tissues are heterogeneous. Murine dorsal wounds also differ from human diabetic foot ulcers in contraction, loading, chronicity and vascular disease. A proposed neural mechanism must therefore be tested against epithelial and barrier outcomes, adequate perfusion and matched glycaemic exposure. Opposing metabolic and endothelial findings, together with compound- and route-specific safety concerns, preclude a general prediction of benefit. The review provides an auditable evidence map and falsifiable experimental priorities; it does not support clinical progesterone supplementation for diabetes-related foot ulcers.
SN - 1663-9812
ER -